e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Inflammation and remodelling in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD
Beata Olejnicka (, Sweden), Daniel Popa, Gustaf Lejonberg, Jonas Erjefält, Beata Olejnicka
Source:
International Congress 2015 – Inflammation and remodelling in lung disease
Session:
Inflammation and remodelling in lung disease
Session type:
Thematic Poster Session
Number:
3922
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Beata Olejnicka (, Sweden), Daniel Popa, Gustaf Lejonberg, Jonas Erjefält, Beata Olejnicka. Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD. Eur Respir J 2015; 46: Suppl. 59, 3922
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Correlation between immunohistochemical CuZn-SOD expression and the histopathological features in small airways of patients with severe COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Histopathologic and immunohistochemical characterization of antioxidants profiles in different compartments in severe COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Quantitative immunohistochemical differences between catalase and thioredoxin in different anatomic compartments of the lung in severe COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Bronchial epithelial gene expression of NOX isoforms are related to important clinical characteristics in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
The expression of antioxidants in small airways in COPD is increased, heterogeneous and correlates with local histopathological alterations
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Increased small intestinal permeability during severe acute exacerbations of COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Monitoring oxidative stress in the lung: Changes in superoxide dismutase (SOD) activity during the course of acute exacerbations in COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Role of peroxiredoxin 6 in lipopolysaccharide-induced mucin production in mice
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept